Changing the daily injection of glatiramer acetate to a monthly long acting product through designing polyester-based polymeric microspheres

[Image: see text] Introduction: Glatiramer acetate (GA) is a newly emerged therapeutic peptide to reduce the frequency of relapses in multiple sclerosis (MS). Despite its good performance in controlling MS, it is not widely used due to daily or biweekly subcutaneous injections due to rapid degradati...

Descripción completa

Detalles Bibliográficos
Autores principales: Molavi, Fatima, Barzegar-Jalali, Mohammad, Hamishehkar, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences (TUOMS Publishing Group) 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809140/
https://www.ncbi.nlm.nih.gov/pubmed/36644544
http://dx.doi.org/10.34172/bi.2022.23733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809140/
https://www.ncbi.nlm.nih.gov/pubmed/36644544
http://dx.doi.org/10.34172/bi.2022.23733

Ejemplares similares